Summary: Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the U.S. Food and Drug Administration (FDA) has expanded…
ChemRobotics Pvt. Ltd. © 2023, All Rights Reserved.
Designed and Developed by Ample eBusiness
Category:
Companies
-
-
Aurobindo PharmaceuticalsMerger / Acquisition
Aurobindo Pharma amass Veritaz Healthcare for Rs 171 crore
by adminby adminSummary Pharma major Aurobindo Pharmaceuticals on Monday said it has acquired the business and certain assets of Veritaz Healthcare Limited (VHL) for…
-
Certis Belchim B.V.Global Market
Certis Belchim B.V : a New Company founded by. Mitsui & Co.Ltd.
by adminby adminSummary Mitsui & Co., Ltd. announced the signing of a formal agreement under which a new business would be established by combining…
-
Novo Nordisk
Novo Nordisk expands research collaboration in novel delivery technologies for biologic medicines
by adminby adminSummary : Novo Nordisk announced the expansion of its existing research collaboration in oral drug delivery technologies with the Massachusetts Institute of…
-
CompaniesCovid DrugsPfizer
Pfizer and BioNTech aubmit for U.S. Emergency Use Authorization of an additional booster dose of their COVID-19 vaccine for older adults
by adminby adminSummary : Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced the companies have submitted an application to the U.S. Food…
-
CompaniesModernaPatent LitigationPatentsPfizer
Alnylam Files Patent Infringement Lawsuits Against Pfizer, Moderna
by adminby adminSummary : Alnylam Pharmaceuticals Inc on Thursday filed lawsuits in Delaware federal court against Pfizer Inc and Moderna Inc, claiming their multibillion-dollar…
-
CompaniesMerck & CoMerger / Acquisition
Merck & Co pens $340m pain drug deal with KCL and Wellcome
by adminby adminSummary Merck & Co has announced a deal with King’s College London (KCL) and Wellcome to investigate a new class of painkillers…
-
AstraZenecaCompaniesMerck & CoRegulatoryU.S FDA
AZ, Merck get FDA okay for Lynparza as adjuvant breast cancer therapy
by adminby adminSummary : The FDA has cleared AstraZeneca and Merck & Co’s Lynparza as an adjuvant or neoadjuvant treatment for breast cancer, extending…
-
AstraZenecaRegulatoryU.S FDA
FDA says no to AZ’s Fasenra for nasal polyp indication
by adminby adminSummary : AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic…
-
Alembic PharmaRegulatoryU.S FDA
Alembic Pharmaceuticals bags USFDA nod for Macitentan tablets
by adminby adminSummary : Alembic Pharmaceuticals received a tentative approval from the United States Food & Drug Administration (USFDA) for its Abbreviated New Drug…